1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South and Central America Cell Therapy Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South and Central America Cell Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South and Central America Cell Therapy Market Regional Analysis
6.2 South and Central America Cell Therapy Market Revenue 2017-2027 (US$ Million)
6.3 South and Central America Cell Therapy Market Forecast Analysis
7. South and Central America Cell Therapy Market Analysis – by Therapy Type
7.1 Allogeneic
- 7.1.1 Overview
- 7.1.2 Allogeneic: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Autologous
- 7.2.1 Overview
- 7.2.2 Autologous: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. South and Central America Cell Therapy Market Analysis – by Product
8.1 Consumables
- 8.1.1 Overview
- 8.1.2 Consumables: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Equipment
- 8.2.1 Overview
- 8.2.2 Equipment: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Systems and Software
- 8.3.1 Overview
- 8.3.2 Systems and Software: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. South and Central America Cell Therapy Market Analysis – by Technology
9.1 Viral Vector Technology
- 9.1.1 Overview
- 9.1.2 Viral Vector Technology: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Genome Editing Technology
- 9.2.1 Overview
- 9.2.2 Genome Editing Technology: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Somatic Cell Technology
- 9.3.1 Overview
- 9.3.2 Somatic Cell Technology: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.4 Cell Immortalization Technology
- 9.4.1 Overview
- 9.4.2 Cell Immortalization Technology: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.5 Cell Plasticity Technology
- 9.5.1 Overview
- 9.5.2 Cell Plasticity Technology: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.6 Three-dimensional Technology
- 9.6.1 Overview
- 9.6.2 Three-dimensional Technology: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. South and Central America Cell Therapy Market Analysis – by Application
10.1 Oncology
- 10.1.1 Overview
- 10.1.2 Oncology: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.2 Cardiovascular
- 10.2.1 Overview
- 10.2.2 Cardiovascular: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.3 Orthopedic
- 10.3.1 Overview
- 10.3.2 Orthopedic: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.4 Wound Management
- 10.4.1 Overview
- 10.4.2 Wound Management: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.5 Other Applications
- 10.5.1 Overview
- 10.5.2 Other Applications: South and Central America Cell Therapy Market – Revenue and Forecast, 2017-2027 (US$ Million)
11. South and Central America Cell Therapy Market – South and Central America Analysis
11.1 Overview
11.2 South and Central America
- 11.2.1 South and Central America Cell Therapy Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 11.2.1.1 South and Central America Cell Therapy Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 Brazil:
South and Central America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.1.1 Brazil: South and Central America Cell Therapy Market Breakdown, by Therapy Type
- 11.2.1.1.2 Brazil: South and Central America Cell Therapy Market Breakdown, by Product
- 11.2.1.1.3 Brazil: South and Central America Cell Therapy Market Breakdown, by Technology
- 11.2.1.1.4 Brazil: South and Central America Cell Therapy Market Breakdown, by Application
- 11.2.1.2 Argentina:
South and Central America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.2.1 Argentina: South and Central America Cell Therapy Market Breakdown, by Therapy Type
- 11.2.1.2.2 Argentina: South and Central America Cell Therapy Market Breakdown, by Product
- 11.2.1.2.3 Argentina: South and Central America Cell Therapy Market Breakdown, by Technology
- 11.2.1.2.4 Argentina: South and Central America Cell Therapy Market Breakdown, by Application
- 11.2.1.3 Rest of South and Central America :
South and Central America Cell Therapy Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.3.1 Rest of South and Central America : South and Central America Cell Therapy Market Breakdown, by Therapy Type
- 11.2.1.3.2 Rest of South and Central America : South and Central America Cell Therapy Market Breakdown, by Product
- 11.2.1.3.3 Rest of South and Central America : South and Central America Cell Therapy Market Breakdown, by Technology
- 11.2.1.3.4 Rest of South and Central America : South and Central America Cell Therapy Market Breakdown, by Application
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 NuVasive, Inc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Smith & Nephew
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Bristol-Myers Squibb Company
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Cells for Cells
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations